Zusammenfassung
The ICER of euro37,361 per life-year gained is a conservative estimate. We concluded that despite the high TMZ acquisition costs, the costs per life-year gained are comparable to accepted first-line treatment with chemotherapy in patients with cancer.
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric
Altmetric